Methods of outcomes measurement in nail psoriasis

Dermatology

Volumn 221, Issue SUPPL. 1, 2010, Pages 23-28

  Augustin, M ^a   Ogilvie, A ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b UNIVERSITY HOSPITAL ERLANGEN   (Germany)

Author keywords

Assessment tools; Nail psoriasis; Psoriasis

Indexed keywords

ARTICLE; CLINICAL FEATURE; DISEASE SEVERITY; HUMAN; MEDICAL LITERATURE; NAIL DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSORIASIS; ADULT; CLINICAL TRIAL (TOPIC); FEMALE; MALE; MIDDLE AGED; NAIL DISEASES; PROCEDURES; REPRODUCIBILITY; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

ADULT; CLINICAL TRIALS AS TOPIC; FEMALE; HUMANS; MALE; MIDDLE AGED; NAIL DISEASES; OUTCOME ASSESSMENT (HEALTH CARE); PSORIASIS; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77956023910     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000316177     Document Type: Article

References (26)

1. Schäfer I, Rustenbach SJ, Zimmer L, Augustin M: Prevalence of skin diseases in a cohort of 48,665 employees in Germany. Dermatology 2008; 217: 169-172.
2. Augustin M, Reich K, Glaeske G, Schaefer I, Radtke M: Comorbidity and age-related prevalence of psoriasis: analysis of health insurance data in Germany. Acta Derm Venereol 2010; 90: 147-151.
3. Krueger G, Koo J, Lebwohl M, Menter A, Stern RS, Rolstad T: The impact of psoriasis on quality of life: results of a 1998 National Psoriasis Foundation patient-membership survey. Arch Dermaology 2001; 137: 280-284.
4. Augustin M, Krüger K, Radtke MA, Schwippl I, Reich K: Disease severity, quality of life and health care in plaque-type psoriasis: a multicenter prospective cross-sectional study in Germany. Dermatology 2008; 216: 366-372.
5. Henseler T, Christophers E: Disease concomitance in psoriasis. J Am Acad Dermatol 1995; 32: 982-986.
6. Taylor W, Gladman D, Helliwell P, Marchesoni A, Mease P, Mielants H; CASPAR Study Group: Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54: 2665-2673.
7. Alamanos Y, Voulgari PV, Drosos AA: Incidence and prevalence of psoriatic arthritis: a systematic review. J Rheumatol 2008; 35: 1354-1358.
8. Reich K, Krüger K, Mössner R, Augustin M: Epidemiology and clinical pattern of psoriatic arthritis in Germany: a prospective interdisciplinary epidemiological study of 1,511 patients with plaque-type psoriasis. Br J Dermatol 2009; 160: 1040-1047.
9. Radtke MA, Reich K, Blome C, Rustenbach S, Augustin M: Prevalence and clinical features of psoriatic arthritis and joint complaints in 2,009 patients with psoriais: results of a German national survey. J Eur Acad Dermatol Venereol 2009; 23: 683-691.
10. Sterry W, Strober BE, Menter A; on behalf of the International Psoriasis Council: Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and review. Br J Dermatol 2007; 157: 649-655.
11. Farber EM, Nall L: Nail psoriasis. Cutis 1992; 50: 174-178.
12. Van Laborde S, Scher RK: Developments in the treatment of nail psoriasis, melanonychia striata, and onychomycosis. Dermatol Clin 2000; 18: 37-46.
13. Augustin M, Reich K, Blome C, Schäfer I, Laass A, Radtke MA: Nail psoriasis in Germany: Epidemiology and burden of disease. Br J Dermatol 2010, Epub ahead of print.
14. Rich P, Griffiths CEM, Reich K, Nestle FO, Scher RK, Li S, Xu S, Hsu MC, Guzzo C: Baseline nail disease in patients with moderate to severe psoriasis and response to treatment with infliximab during 1 year. J Am Acad Dermatol 2008; 58: 224-231.
15. Baran RL: A nail psoriasis severity index. Br J Dermatol 2004; 150: 568-569.
16. Cannavò SP, Guarneri F, Vaccaro M, Borgia F, Guarneri B: Treatment of psoriatic nails with topical cyclosporin: a prospective, randomized placebo-controlled study. Dermatology 2003; 206: 153-156.
17. Ortonne JP, Baran R, Corvest M, Schmitt C, Voisard JJ, Taieb C: Development and validation of nail psoriasis quality of life scale (NPQ10). J Eur Acad Dermatol Venereol 2010; 24: 22-27.
18. Rich P, Scher RK: Nail Psoriasis Severity Index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol 2003; 49: 206-212.
19. Lawry M: Biological therapy and nail psoriasis. Dermatol Ther 2007; 20: 60-67.
20. Kacar N, Ergin S, Erdogan BS: The comparison of Nail Psoriasis Severity Index with a less time-consuming qualitative system. J Eur Acad Dermatol Venereol 2008; 22: 219-222.
21. Cassell SE, Bieber JD, Rich P, Tutuncu ZN, Lee SJ, Kalunian KC, Wu CW, Kavanaugh A: The modified Nail Psoriasis Severity Index: validation of an instrument to assess psoriatic nail involvement in patients with psoriatic arthritis. J Rheumatol 2007; 34: 123-129.
22. Aktan S, Ilknur T, Akin C, Ozkan S: Interobserver reliability of the Nail Psoriasis Severity Index. Clin Exp Dermatol 2007; 32: 141-144.
23. Gupta AK, Cooper EA: Psoriatic nail disease: quality of life and treatment. J Cutan Med Surg 2009; 13(suppl 2):S102-S106.
24. Drummond MF, O'Brien BJ, Stoddart GL, Torrance GW: Methods for the Economic Evaluation of Health Care Programmes, ed 2. Oxford, Oxford Medical Publications, 1997.
25. Kerkmann U, Winkelman W, Wang Y, Reich K: Target nail NAPSI correlates with number of nails involved: a clinically efficient, useful, and precise assessment for nail psoriasis severity (poster). Presented at the 18th Congress of the European Academy of Dermatology and Venereology, 7-11 October 2009, Berlin, Germany, poster 1164.
26. Augustin M, Amon U, Braathen L, Bullinger M, Gieler U, Klein GF, Schultz-Amling W: Assessment of quality of life in dermatology (German national guideline). J Dtsch Dermatol Ges 2004; 9: 802-806.